Oral probiotics in coronavirus disease 2019: connecting the gut-lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials.

Baindara, P; Chakraborty, R; Holliday, Z M; Mandal, S M; Schrum, A G

Baindara, P; Chakraborty, R; Holliday, Z M; Mandal, S M; Schrum, A G.

Afiliação

Baindara P; Department of Molecular Microbiology & Immunology, School of Medicine, University of Missouri, Columbia, MO, USA.
Chakraborty R; Department of Biotechnology, North Bengal University, Darjeeling, India.
Holliday ZM; Pulmonary Disease, Critical Care Medicine, School of Medicine, University of Missouri, Columbia, MO, USA.
Mandal SM; Central Research Facility, Indian Institute of Technology Kharagpur, Kharagpur, India.
Schrum AG; Department of Molecular Microbiology & Immunology, School of Medicine, University of Missouri, Columbia, MO, USA.

New Microbes New Infect ; 40: 100837, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33425362

Palavras-chave

Coronavirus disease 2019; gut microbiome; gutlung axis; probiotics; secondary infection; severe acute respiratory syndrome coronavirus 2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies Idioma: En Revista: New Microbes New Infect Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google